re: Ann: FDA agrees on potential regulatory p... The usual wording that does not inspire confidence "potential regulatory path to progress OMAPRO"
and the timeline only for the patient: "we plan to submit our new NDA to the FDA by the end of the year" Seeing is believing
re: Ann: FDA agrees on potential regulatory p... The usual...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)